Equity Overview
Price & Market Data
Price: $7.54
Daily Change: -$0.02 / 0.27%
Range: $7.47 - $7.69
Market Cap: $291,592,160
Volume: 15,374
Performance Metrics
1 Week: -1.69%
1 Month: 24.42%
3 Months: -28.28%
6 Months: -5.38%
1 Year: -10.98%
YTD: -5.75%
Company Details
Employees: 183.6
Sector: Health technology
Industry: Medical specialties
Country: Belgium
Details
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.